v3.26.1
Segment Information
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information

3. Segment Information

 

The following table presents the significant segment expenses (10% or greater) and other segment items regularly reviewed by the Company’s CODM and included in research and development costs for the three and six months and June 30, 2026 and 2025.

 

             
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Clinical and related oversight costs  $15,018   $11,601   $324,812   $27,470 
Preclinical research focused on development of additional novel anti-cancer compounds   47,077    27,592    70,659    70,362 
Compound maintenance   -    20,265    -    53,083 
Regulatory service costs   155    1,190    155    1,190 
Total research and development costs  $62,250   $60,648   $395,626   $152,105 

 

The following table presents a summary of research and development costs for the three and six months ended June 30, 2026 and 2025 based on the respective geographical regions where such costs were incurred.

 

             
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
United States  $40,119   $41,928   $79,092   $100,499 
Spain   22,131    18,720    316,534    51,606 
Total  $62,250   $60,648   $395,626   $152,105 

 

The following table presents the significant segment expenses (10% or greater) and other segment items regularly reviewed by the Company’s CODM and included in general and administrative costs for the three and six months ended June 30, 2026 and 2025.

 

             
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Stock-based compensation  $622,614   $240,499   $704,790   $312,737 
Quarterly board fees   29,258    27,500    (27,775)   55,000 
Patent and licensing legal and filing fees costs   30,785    17,303    65,817    73,386 
Marketing and public relations   139,000    -    370,900    - 
Accounting and bookkeeping services   172,975    72,337    559,681    167,356 
Audit and legal   102,169    84,474    167,775    165,911 
Consulting fees   103,047    29,811    275,744    57,315 
Insurance expense   64,387    64,277    128,774    128,553 
Investment banking   -    19,740    250,000    48,600 
Payroll   226,842    104,948    444,769    195,711 
Lease   152,306    -    297,671    - 
Other costs and expenses, net   644,287    53,272    703,555    125,075 
Total general and administrative costs  $2,287,670   $714,161   $3,941,701   $1,329,644